Novartis' CEO Says Getting Momentum Back in Alcon Unit

Joe Jimenez, chief executive officer at Novartis, discusses second-quarter earnings, the revival at its Alcon eye-care division, the possible IPO for the Alcon unit, their joint venture with Glaxo and drug pricing in the U.S. He speaks on "Bloomberg Daybreak: Europe." (Source: Bloomberg)

Full Show: What'd You Miss? (07/18)
43:16 - Guests include: Hoover Institution's Lanhee Chen, Moody's Analytics' Adam Ozimek and Civic CEO Vinny Lingham. (Source: Bloomberg)
  • Full Show: Bloomberg Technology (07/18)
  • Full Show: Surveillance (07/18)
  • Novartis' CEO Says Getting Momentum Back in Alcon Unit